Moyse E, Rostène W, Vial M, Leonard K, Mazella J, Kitabgi P, Vincent J P, Beaudet A
Montreal Neurological Institute, Quebec, Canada.
Neuroscience. 1987 Aug;22(2):525-36. doi: 10.1016/0306-4522(87)90350-2.
The topographic distribution of specifically labeled neurotensin binding sites was examined by light microscopic radioautography in rat brain sections incubated with monoiodo [125I]Tyr3-neurotensin. Preliminary experiments indicated that under the present experimental conditions [125I]neurotensin specifically binds to a single apparent population of sites with a dissociation constant of 7.7 +/- 0.3 nM, and that fixation of the labeled sections with glutaraldehyde ensures regionally proportional retention of more than 70% of bound [125I]neurotensin molecules. High concentrations of [125I]neurotensin binding sites were detected in the olfactory bulb and tubercle, parts of the neocortex, the lateral septum, the diagonal band of Broca, the caudate putamen, the amygdala, the dentate gyrus, the anterior dorsal nucleus of the thalamus, the suprachiasmatic nucleus of the hypothalamus, the medial habenula, the zona incerta, the substantia nigra and the ventral tegmental area. In certain areas, such as in the diagonal band of Broca, the substantia innominata, the nucleus basalis and the pars compacta of the substantia nigra, discrete accumulations of silver grains were apparent over neuronal perikarya and their proximal dendrites. In most areas, however, the label appeared more or less uniformly distributed over nerve cell bodies and surrounding neuropil. In several instances, the labeling conformed with the distribution of cell bodies of origin and terminal aborizations of specific projection systems, suggesting that neurotensin receptors might be distributed both proximally and distally on the plasma membrane of certain neurons. Such putative "neurotensinoceptive" projection systems might involve part of the mesostriatal, mesocortical and mesolimbic dopamine systems, as well as the raphe-prosencephalic serotonin system and the habenulo-interpeduncular and basal forebrain-cortical cholinergic systems. Finally, areas of dense [125I]neurotensin labeling often corresponded to zones previously shown to exhibit intense acetylcholinesterase staining, suggesting the existence of a possible link between the expression of neurotensin binding sites and that of acetylcholinesterase in certain neuronal populations.
通过光学显微镜放射自显影法,在与单碘[¹²⁵I]酪氨酸³ - 神经降压素孵育的大鼠脑切片中,检查了特异性标记的神经降压素结合位点的拓扑分布。初步实验表明,在当前实验条件下,[¹²⁵I]神经降压素特异性结合到单一明显的位点群体,解离常数为7.7±0.3 nM,并且用戊二醛固定标记切片可确保区域比例保留超过70%的结合[¹²⁵I]神经降压素分子。在嗅球和结节、新皮层的部分区域、外侧隔、布罗卡斜带、尾状壳核、杏仁核、齿状回、丘脑前背核、下丘脑视交叉上核、内侧缰核、未定带、黑质和腹侧被盖区检测到高浓度的[¹²⁵I]神经降压素结合位点。在某些区域,如布罗卡斜带、无名质、基底核和黑质致密部,在神经元胞体及其近端树突上可见离散的银粒聚集。然而,在大多数区域,标记物在神经细胞体和周围神经毡上或多或少均匀分布。在一些情况下,标记与特定投射系统的起源细胞体和终末分支的分布一致,这表明神经降压素受体可能在某些神经元的质膜上近端和远端均有分布。这种假定的“神经降压素感受性”投射系统可能涉及中脑纹状体、中脑皮质和中脑边缘多巴胺系统的一部分,以及中缝 - 前脑5 - 羟色胺系统和缰核 - 脚间核及基底前脑 - 皮质胆碱能系统。最后,[¹²⁵I]神经降压素标记密集的区域通常对应于先前显示有强烈乙酰胆碱酯酶染色的区域,这表明在某些神经元群体中神经降压素结合位点的表达与乙酰胆碱酯酶的表达之间可能存在联系。